Catalyst Health Ventures
43
8M
21
1.87
8
0.51
10
- Stages of investment
- Areas of investment
Summary
In 1998 was created Catalyst Health Ventures, which is appeared as VC. The main office of represented VC is situated in the Braintree. The company was established in North America in United States.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Catalyst Health Ventures, startups are often financed by Versant Ventures, Tribeca Venture Partners, Rainfall Ventures. The meaningful sponsors for the fund in investment in the same round are Domain Associates, Tribeca Venture Partners, Rainfall Ventures. In the next rounds fund is usually obtained by Domain Associates, Upstart Capital, Tribeca Venture Partners.
The current fund was established by Kevin McCafferty. Besides them, we counted 7 critical employees of this fund in our database.
Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Maxwell Health, Sera Prognostics, Novazyme Pharmaceuticals. We can highlight the next thriving fund investment areas, such as Biotechnology, Education. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The increased amount of exits for fund were in 2018. Speaking about the real fund results, this VC is 23 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 5 - 10 millions dollars. The high activity for fund was in 2011. Opposing the other organizations, this Catalyst Health Ventures works on 9 percentage points less the average amount of lead investments. The fund is constantly included in less than 2 deals per year.
Investments analytics
Analytics
- Total investments
- 43
- Lead investments
- 8
- Exits
- 10
- Rounds per year
- 1.87
- Follow on index
- 0.51
- Investments by industry
- Health Care (34)
- Medical Device (27)
- Biotechnology (23)
- Medical (20)
- Hospital (6) Show 17 more
- Investments by region
-
- United States (43)
- Peak activity year
- 2011
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Avg. valuation at time of investment
- 46M
- Group Appearance index
- 0.67
- Avg. company exit year
- 8
- Avg. multiplicator
- 3.40
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
nVision Medical | 25 Apr 2013 | Biotechnology, Health Care, Medical | Early Stage Venture | 4M | United States, California |
Oasis Hunters | 26 Apr 2021 | Travel, Tourism | Seed | 159K | Barcelona, Catalonia, Spain |
PanTher Therapeutics | 19 May 2021 | Biotechnology, Medical, Therapeutics | Early Stage Venture | 5M | United States, Massachusetts, Cambridge |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.